top of page

Biotech Executive Michael Ackermann Joins Solas BioVentures

November 4, 2021

Healthcare Executive Jarrett Millsaps Joins Solas BioVentures​

November 2, 2021

Tvardi Therapeutics Raises $74 Million in Series B Financing to Advance Clinical Programs

June 23, 2021

Francis Medical Announces Positive Data from VAPOR 1 IDE Study for Water Vapor Ablation of Prostate Cancer

June 8, 2021

Baebies Announces FDA Acknowledgement of Emergency Use Notification for FINDER 1.5 Instrument and FINDER SARS-CoV-2 Test – RT-PCR within 17 Minutes

April 5, 2021

NX Prenatal Announces Initiation of a Clinical Study for the Detection of Placenta Accreta

April 1, 2021

Stimdia Medical Receives FDA Breakthrough Device Designation for the pdSTIM™ System Designed to Facilitate Weaning Patients from Mechanical Ventilation

March 18, 2021

Tvardi Therapeutics Appoints Michael Wyzga, Former CFO of Genzyme, to Board of Directors

March 11, 2021

Vesalio Receives Peripheral FDA 510k Clearance and Additional CE Approval

January 28, 2021

Tvardi Therapeutics Appoints Sujal Shah to Board of Directors

January 28, 2021

NX Prenatal Expands Leading Patent Position in Exosome-Based Liquid Biopsy Tests in Maternal- Fetal Medicine

January 27, 2021

Renovia names new president and CEO; Completes enrollment for randomized controlled trial.

January 19, 2021

Knopp Biosciences Announces Positive Top-Line Results from the Phase 2 EXHALE Trial of Oral Dexpramipexole in Moderate-to-Severe Eosinophilic Asthma

January 14, 2021

InterShunt Announces Equity Financing Led by Solas BioVentures with participation from Arsenal Capital Management and a select group of industry executives.

January 11, 2021

bottom of page